Nvidia Corp has launched what it claims is the fastest U.K. supercomputer for outside researchers, which includes scientists as well as commercial companies such as AstraZeneca and GlaxoSmithKline.<\/p>\n\n\n\n
Nvidia has spent about $100 million on its Cambridge-1 system, which uses artificial intelligence to solve problems in health research.<\/p>\n\n\n\n
In the case of AstraZeneca, for example, the system learns about 1 billion chemical compounds represented by character groups that can be assembled into sentence structures.<\/p>\n\n\n\n
Cambridge-1 is aimed at researchers who already use smaller Nvidia-based systems for research.<\/p>\n\n\n\n
Nvidia said it is offering the system for free and it will use what it learns from operating the system to improve its future healthcare products.<\/p>\n\n\n\n
Nvidia is taking steps to show a commitment to the U.K. as it works to complete its $40 billion takeover of ARM Ltd from Japan’s SoftBank Group Corp.<\/p>\n\n\n\n
The U.K. antitrust authorities are investigating the takeover, which would transfer ownership of one of the U.K.’s technological jewels from one foreign company to another.<\/p>\n\n\n\n
In connection with the deal, Nvidia has said that it also plans to build a supercomputing center in the U.K. using ARM-designed chips.<\/p>\n\n\n